The Center for Cancer and Blood Disorders at Children’s Hospital Colorado offers the region’s only dedicated pediatric bone marrow transplant (BMT) program. Established in 1994, the team performs 50 to 60 bone marrow transplants each year for children, teens and young adults with hematologic, oncologic, immunologic and hereditary metabolic conditions.
The program has been accredited by the Foundation for Accreditation of Cellular Therapy (FACT) since 2001. This certification is based on patient volumes, qualified staff, suitable facilities and having a comprehensive quality assurance program that meets current national FACT standards. This accreditation means our team has been consistently recognized through national peer review for high-quality patient care and laboratory performance for bone marrow transplant. Children are in good hands at Children's Hospital Colorado.
Our program is also an approved transplant site of the National Marrow Donor Program (NMDP), the Children’s Oncology Group (COG) and the Pediatric BMT Consortium.
Why choose Children’s Hospital Colorado?
Children’s Colorado is recognized as meeting the highest standards of 100-day and one-year post-BMT survival compared to other U.S. pediatric BMT programs by the International Bone Marrow Transplant Registry, the NMDP and U.S. News and World Report. See our BMT survival rates.
Optimal transplant care for teenagers and young adults
Research has shown that teens needing a bone marrow transplant do better when treated on pediatric protocols and in a pediatric setting.
Collaboration with referring providers
All team members are committed to providing excellent service to patients and providers through immediate call-back and evaluation for urgent referrals. Streamlined communication also occurs before, during and after transplantation. Get more information for healthcare professionals.
What does our Pediatric Bone Marrow Transplant Program offer?
Our multidisciplinary program includes:
- Consultation, evaluation, treatment and follow-up care
- BMT-trained pediatric physicians, nurse practitioners and physician assistants
- Board-certified pediatricians and pediatric hematologists/oncologists
- A pediatric radiation oncologist
- Dedicated, BMT-trained nursing staff
- A pediatric pharmacist
- A HEPA-filtered, positive pressure inpatient Bone Marrow Transplant (BMT) unit
- Trained BMT coordinators to organize allogeneic donor selection and pre-BMT evaluation
- BMT-specific outpatient team and clinic services
- Stem cell processing laboratory on site
- Technology to procure and process stem cells from marrow, peripheral blood and cord blood
- Availability of both autologous and allogeneic transplant methods and expertise
- Numerous state-of-the-art local and national clinical trials in pediatric hematopoietic stem cell transplant
- Access to all unrelated donor registries (NMDP, Caitlin Raymond International, Cord Blood)
- A Children’s Oncology Group (COG) Transplant Center
- A National Marrow Donor Program Transplant Center
- Treatment of patients from birth to 25 years of age
Support services for your family:
Innovation and research to advance pediatric bone marrow transplantation
- An insurance liaison to assist physicians and families with financial approval
- Established contracts for transplant care with numerous insurers
- Patient and family support from social workers, clinical psychologists, recreational therapists, child life specialists, pastoral care and others
- A Spanish-speaking care team and foreign language translators to facilitate communication and understanding of treatment plans as well as improve medical compliance
- Access to private apartments at Brent’s Place, a safe-clean housing facility specifically designed for immune-compromised patients that is located near the hospital
- Comprehensive late-effects and survivorship services designed to help young patients lead healthier lives post-transplant
Members of the team are actively involved in research in pediatric bone marrow transplant with the goal of improving BMT outcomes. Our team performed its first cord blood transplant in 1996, early in the investigation of this now common stem cell source. Today, we continue to have ongoing research projects that focus on optimizing the success of BMT for many pediatric disorders.